Have questions about how to conduct an early phase study in a patient population? You aren’t alone. Since our recent completion of an early phase study with rare disease patients, we have had numerous sponsors reach out to ask just that–“how did you do it?” So, we wrote a white paper.
Find out everything you need to know to run a successful Phase I patient study in this whitepaper.
Authors:
Michael Murphy, MD, PhD
Chief Medical and Scientific Officer
Derek Ansel, MS, LCGC
Vice President, Therapeutic Strategy Lead, Rare Disease
